Rosetta Genomics Ltd (NASDAQ:ROSG)

0.45
Delayed Data
As of Feb 20
 -0.01 / -2.17%
Today’s Change
0.42
Today|||52-Week Range
6.00
-18.92%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Rosetta Genomics Ltd have a median target of 0.60, with a high estimate of 0.60 and a low estimate of 0.60. The median estimate represents a +33.33% increase from the last price of 0.45.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Hold stock in Rosetta Genomics Ltd. This rating has held steady since February, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.84
Sales
$3.0M
Reporting Date
Apr 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 61.11%
 
 
 
 
 
 
Growthannually 55.65%
 
 
 
 
 
 

Sales

Growthquarterly 36.36%
 
 
 
 
 
 
Growthannually 30.62%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.